DBV Technologies

DBV Technologies is a biotechnology company focused on developing innovative treatments for allergies and immune-related conditions. Their core approach uses a special delivery system called the Viasker, which administers allergy vaccines through the skin without needles, aiming to improve safety and patient experience. Their lead product targets peanut allergies, working to desensitize individuals and reduce allergic reactions. By advancing this technology, DBV aims to provide effective, needle-free allergy therapies that can improve quality of life for patients with severe allergies.